JPS55141469A - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
JPS55141469A
JPS55141469A JP4577180A JP4577180A JPS55141469A JP S55141469 A JPS55141469 A JP S55141469A JP 4577180 A JP4577180 A JP 4577180A JP 4577180 A JP4577180 A JP 4577180A JP S55141469 A JPS55141469 A JP S55141469A
Authority
JP
Japan
Prior art keywords
piperidine derivatives
piperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4577180A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0132823B2 (en, 2012
Inventor
Ei Kaa Arubaato
Ii Dorufuini Jiyosefu
Jiei Raito Jiyooji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21845568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55141469(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of JPS55141469A publication Critical patent/JPS55141469A/ja
Publication of JPH0132823B2 publication Critical patent/JPH0132823B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP4577180A 1979-04-10 1980-04-09 Piperidine derivatives Granted JPS55141469A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/028,813 US4254129A (en) 1979-04-10 1979-04-10 Piperidine derivatives

Publications (2)

Publication Number Publication Date
JPS55141469A true JPS55141469A (en) 1980-11-05
JPH0132823B2 JPH0132823B2 (en, 2012) 1989-07-10

Family

ID=21845568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4577180A Granted JPS55141469A (en) 1979-04-10 1980-04-09 Piperidine derivatives

Country Status (19)

Country Link
US (1) US4254129A (en, 2012)
JP (1) JPS55141469A (en, 2012)
AT (1) AT376208B (en, 2012)
AU (1) AU531146B2 (en, 2012)
BE (1) BE882703A (en, 2012)
CA (1) CA1123438A (en, 2012)
CH (1) CH643245A5 (en, 2012)
DE (1) DE3007498A1 (en, 2012)
DK (1) DK153709C (en, 2012)
ES (1) ES489934A0 (en, 2012)
FR (1) FR2453854A1 (en, 2012)
IL (1) IL59158A (en, 2012)
IT (1) IT1143960B (en, 2012)
NL (2) NL190580C (en, 2012)
NO (2) NO154521C (en, 2012)
NZ (1) NZ192653A (en, 2012)
PH (1) PH17023A (en, 2012)
SE (1) SE448726B (en, 2012)
ZA (1) ZA80332B (en, 2012)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01128924A (ja) * 1987-10-07 1989-05-22 Merrell Dow Pharmaceut Inc ピペリジノアルカノール誘導体の製剤組成物
JPH08500348A (ja) * 1992-08-03 1996-01-16 セプラコア インコーポレーテッド アレルギー疾患治療用のテルフェナジン代謝物及びその光学的に純粋な異性体
JP2001526232A (ja) * 1997-12-23 2001-12-18 シェーリング コーポレイション 少なくとも一つのロイコトリエンアンタゴニストおよび少なくとも一つの抗ヒスタミン剤を含有する呼吸器および皮膚疾患処置のための組成物
WO2006095723A1 (ja) * 2005-03-07 2006-09-14 National University Corporation Kumamoto University 抗アレルギー薬
JP2008094848A (ja) * 2001-06-18 2008-04-24 Dr Reddys Lab Ltd 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩
JP2008266347A (ja) * 1995-02-28 2008-11-06 Aventis Pharmaceuticals Inc ピペリジノアルカノール化合物のための医薬組成物
JP2009161521A (ja) * 1993-06-25 2009-07-23 Aventis Inc 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
JP2009544691A (ja) * 2006-07-27 2009-12-17 アルキミカ ソシエタ ア レスポンサビリタ リミタータ フェキソフェナジンの調製方法
JP2010120969A (ja) * 1994-05-18 2010-06-03 Aventis Holdings Inc 抗ヒスタミン性ピペリジン誘導体およびその製造方法

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
CN1053570C (zh) 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
TW198008B (en, 2012) * 1991-04-08 1993-01-11 Green Cross Corp
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
CA2129995C (en) * 1992-02-13 2000-04-11 Albert A. Carr Piperidinyl thiacyclic derivatives
PT635004E (pt) * 1992-04-10 2002-12-31 Merrell Pharma Inc Derivados da 4-difenilmetil piperidina e processo para a sua preparacao
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
ES2121084T3 (es) * 1992-05-11 2002-02-16 Merrell Pharma Inc Utilizacion de derivados de terfenadina como antihistaminicos en un paciente que padece de trastornos hepaticos.
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
PT1026147E (pt) * 1993-06-24 2004-04-30 Albany Molecular Res Inc Compostos uteis como intermediarios na producao de derivados de piperidina
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
WO1995010278A1 (en) * 1993-10-15 1995-04-20 Hoechst Marion Roussel, Inc. Treatment of allergic disorders with terfenadine carboxylate
JPH09509138A (ja) * 1993-10-25 1997-09-16 メレルファーマスーティカルズ インコーポレイテッド ターフェナジン及びイブプロフェンの安定な製剤組成物
WO1995031436A1 (en) * 1994-05-16 1995-11-23 Merrell Pharmaceuticals Inc. PROCESS AND DIASTEREOMERIC SALTS USEFUL FOR THE OPTICAL RESOLUTION OF RACEMIC α-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINEBUTANOL AND DERIVATIVE COMPOUNDS
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CN101337922A (zh) * 1994-05-18 2009-01-07 阿温蒂斯药物公司 抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
NZ292683A (en) 1994-08-25 1998-07-28 Merrell Pharma Inc Piperidine derivatives
KR19990008406A (ko) * 1995-05-08 1999-01-25 스티븐엘.네스비트 알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US5906747A (en) * 1995-11-13 1999-05-25 Biosepra Inc. Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
DK0864653T3 (da) * 1997-03-11 2004-07-12 Aventis Pharma Inc Fremgangsmåde til fremstilling af 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alfa,alfa-dimethylphenyleddikesyre og phosphorylerede derivater deraf
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
EE04263B1 (et) * 1997-08-14 2004-04-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
ES2200260T3 (es) * 1997-12-17 2004-03-01 Aventis Pharma Deutschland Gmbh Procedimiento para la alquilacion de derivados de alquil-o bencilciano en presencia de trialquilaminas o trialquifosfinas.
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
HUP0104159A3 (en) * 1998-07-02 2002-04-29 Aventis Pharmaceuticals Inc Br Novel antihistaminic piperidine derivatives and intermediates and process for the preparation thereof and medicaments containing them
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
IN191492B (en, 2012) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
CH695216A5 (de) * 2001-02-23 2006-01-31 Cilag Ag Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
AU2002305162A1 (en) * 2001-04-09 2002-10-21 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US7700779B2 (en) 2001-06-18 2010-04-20 Dr. Reddy's Laboratories Limited Crystalline forms of fexofenadine and its hydrochloride
US20030158227A1 (en) * 2001-11-08 2003-08-21 Barnaba Krochmal Polymorphs of fexofenadine base
CA2465913A1 (en) * 2001-11-08 2003-05-15 Judith Aronhime Polymorphs of fexofenadine base
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
AU2003248657A1 (en) * 2002-06-10 2003-12-22 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
EP1575893A1 (en) * 2002-12-16 2005-09-21 Ranbaxy Laboratories Limited Process for the preparation of fexofenadine
CA2514610A1 (en) * 2003-01-31 2004-08-12 Ranbaxy Laboratories Limited Process for the preparation of fexofenadine
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
JP2007532687A (ja) * 2004-04-26 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩酸塩の結晶形およびその製造方法
WO2006008567A1 (en) * 2004-06-18 2006-01-26 Wockhardt Limited Pharmaceutical compositions for piperidinoalkanol compounds
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
EP1685106A2 (en) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Fexofendadine crystal form and processes for its preparation thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP5607291B2 (ja) * 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
BRPI0614231A2 (pt) * 2005-08-05 2012-12-11 Lupin Ltd composições farmacêuticas de fexofenadina em forma de suspensão oral
US20070088065A1 (en) * 2005-10-14 2007-04-19 Jie Du Metaxalone products, method of manufacture, and method of use
US20080292584A1 (en) * 2005-10-14 2008-11-27 Mutual Pharmaceutical Company, Inc. Metaxalone products, method of manufacture, and method of use
RU2283649C1 (ru) * 2005-10-27 2006-09-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
WO2007049303A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of highly pure fexofenadine
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
DOP2006000274A (es) * 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
CN100443470C (zh) * 2006-07-21 2008-12-17 杭州保灵有限公司 一种依巴斯汀的制备方法
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN101940571A (zh) 2007-04-13 2011-01-12 南方研究所 抗血管生成剂和使用方法
ITMI20070987A1 (it) * 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
US20090076080A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched fexofenadine
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
US20090304826A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for dermatoses
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
CN101585805B (zh) * 2009-06-06 2011-07-06 浙江大学宁波理工学院 一种抗过敏药物非索非那定盐酸盐的制备方法
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
CN101671292B (zh) * 2009-10-10 2011-09-07 浙江大学宁波理工学院 盐酸非索非那定的合成方法
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
EP2371817A1 (en) * 2010-04-01 2011-10-05 Arevipharma GmbH Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof
US9216955B2 (en) 2010-06-15 2015-12-22 Chemelectiva S.R.L. Polymorphic form of Fexofenadine hydrochloride, intermediates and process for its preparation
RU2013156864A (ru) 2011-05-23 2015-06-27 Санофи Способ получения дейтерированных соединений, содержащих n-алкильные группы
AR088204A1 (es) 2011-09-29 2014-05-14 Shionogi & Co Medicamentos para el tratamiento de la rinitis alergica que comprenden un antagonista de pgd2 y un antagonista de histamina
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
CN103333100B (zh) * 2013-06-06 2016-04-06 池州东升药业有限公司 一种盐酸非索非那定的合成工艺
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
CN104557671B (zh) * 2013-10-10 2018-04-13 池州东升药业有限公司 一种非索非那定及中间体的合成方法
EP2949321A1 (en) 2014-05-26 2015-12-02 Sanovel Ilac Sanayi ve Ticaret A.S. Multilayer formulations of fexofenadine and montelukast
DK3247699T3 (da) 2015-01-22 2019-08-12 Sanofi Aventis Deutschland Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
PL3365327T3 (pl) 2015-10-22 2020-05-18 Sanofi-Aventis Deutschland Gmbh Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie
GB2629127A (en) 2022-08-31 2024-10-23 Novumgen Ltd An orodispersible tablet of fexofenadine and its process of preparation
CN118714999A (zh) 2023-01-20 2024-09-27 欧彼乐医疗集团公司 不含对羟基苯甲酸酯的非索非那定制剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4885578A (en, 2012) * 1972-01-28 1973-11-13
JPS50108266A (en, 2012) * 1974-02-08 1975-08-26
JPS50108265A (en, 2012) * 1974-02-08 1975-08-26

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4885578A (en, 2012) * 1972-01-28 1973-11-13
JPS50108266A (en, 2012) * 1974-02-08 1975-08-26
JPS50108265A (en, 2012) * 1974-02-08 1975-08-26

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01128924A (ja) * 1987-10-07 1989-05-22 Merrell Dow Pharmaceut Inc ピペリジノアルカノール誘導体の製剤組成物
JPH08500348A (ja) * 1992-08-03 1996-01-16 セプラコア インコーポレーテッド アレルギー疾患治療用のテルフェナジン代謝物及びその光学的に純粋な異性体
JP2000086516A (ja) * 1992-08-03 2000-03-28 Sepracor Inc テルフェナジンカルボキシレ―トの使用方法
JP2009161521A (ja) * 1993-06-25 2009-07-23 Aventis Inc 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
JP2010120969A (ja) * 1994-05-18 2010-06-03 Aventis Holdings Inc 抗ヒスタミン性ピペリジン誘導体およびその製造方法
JP2008266347A (ja) * 1995-02-28 2008-11-06 Aventis Pharmaceuticals Inc ピペリジノアルカノール化合物のための医薬組成物
JP2001526232A (ja) * 1997-12-23 2001-12-18 シェーリング コーポレイション 少なくとも一つのロイコトリエンアンタゴニストおよび少なくとも一つの抗ヒスタミン剤を含有する呼吸器および皮膚疾患処置のための組成物
JP2008094848A (ja) * 2001-06-18 2008-04-24 Dr Reddys Lab Ltd 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩
WO2006095723A1 (ja) * 2005-03-07 2006-09-14 National University Corporation Kumamoto University 抗アレルギー薬
JP2009544691A (ja) * 2006-07-27 2009-12-17 アルキミカ ソシエタ ア レスポンサビリタ リミタータ フェキソフェナジンの調製方法

Also Published As

Publication number Publication date
NL190580B (nl) 1993-12-01
ES8103735A1 (es) 1981-03-16
ES489934A0 (es) 1981-03-16
AT376208B (de) 1984-10-25
AU5501680A (en) 1980-10-16
NL980013I2 (nl) 1998-10-01
FR2453854B1 (en, 2012) 1983-06-24
ZA80332B (en) 1981-01-28
FR2453854A1 (fr) 1980-11-07
DK153709C (da) 1988-12-27
NL190580C (nl) 1994-05-02
AU531146B2 (en) 1983-08-11
DE3007498A1 (de) 1980-10-23
NO154521C (no) 1986-10-08
SE448726B (sv) 1987-03-16
IL59158A0 (en) 1980-05-30
IL59158A (en) 1984-04-30
IT8048245A0 (it) 1980-03-24
CA1123438A (en) 1982-05-11
NL8000754A (nl) 1980-10-14
ATA144880A (de) 1984-03-15
NO801014L (no) 1980-10-13
SE8002634L (sv) 1980-10-11
PH17023A (en) 1984-05-11
CH643245A5 (de) 1984-05-30
DK153709B (da) 1988-08-22
BE882703A (fr) 1980-07-31
DK132980A (da) 1980-10-11
NO154521B (no) 1986-06-30
JPH0132823B2 (en, 2012) 1989-07-10
US4254129A (en) 1981-03-03
NZ192653A (en) 1982-03-16
NL980013I1 (nl) 1998-06-02
NO1998017I1 (no) 1998-05-29
IT1143960B (it) 1986-10-29
DE3007498C2 (en, 2012) 1989-09-07

Similar Documents

Publication Publication Date Title
JPS55141469A (en) Piperidine derivatives
ZA80331B (en) Piperidine derivatives
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2044254B (en) Piperidine derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
CU35300A (en) Pyrrholidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2055368B (en) E-homoeburnane derivatives
GB2062464B (en) Eburnamenine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
JPS5626875A (en) 44*naphthaleniloxy*piperidine derivatives
HK55483A (en) Isopropylamino-pyrimidine derivatives
GB2056439B (en) Hexahydroazepine derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2048258B (en) Piperidine derivatives
GB2061932B (en) Piperidine derivatives
GB2105326B (en) Piperidine derivatives
GB2065110B (en) Decaprenylamine derivatives